Home > Insider Trading > Filing (0001213900-20-010932)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1211583	Fennec Pharmaceuticals Inc.	FENC	()	1231

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1092601	Spa Essetifin	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1163608	Paolo Cavazza	Via Tesserete, 10 Lugano V8 0000	No	No	Yes	No
1525742	Francesca Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1525743	Silvia Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1525744	Enrico Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No
1718557	Martina Preta Cavazza	Via Sudafrica, 20 Rome L6 00144	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-30	768,000	$6.25	3,993,694	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Such shares were purchased in connection with an underwritten public offering by the issuer, which closed on May 4, 2020.
Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.